GSK rises Wednesday, outperforms market
GSK PLC closed 18.56% below its 52-week high of £18.24, which the company reached on May 16th.
STAT23d
Pharmalittle: We’re reading about J&J and GSK deals, a departing FDA official, and more
Intra-Cellular last month filed the drug with U.S. regulators as a treatment that could be combined with regular antidepressants to treat major depressive ... business, GSK agreed to buy IDRx ...